Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Topics Community

Article

Ovarian cancer: identifying and managing familial and genetic risk-summary of new NICE guidance.

BMJ (Clinical research ed.) - 9 May 2024

Slade Eric, Berg Laura, Dworzynski Katharina, Manchanda Ranjit

Abstract excerpt

No abstract is available from the source.

Topics

Humans
Female
Ovarian Neoplasms
Genetic Predisposition to Disease
Genetic Testing
Practice Guidelines as Topic
Risk Assessment
Risk Factors
United Kingdom

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 38724099
DOI: 10.1136/bmj.q807

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 31 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Ovarian cancer: identifying and managing familial and genetic risk-summary of new NICE guidance.PMID 38724099Read ↗

Epithelial ovarian cancer risk: A review of the current genetic landscapeSemantic proximity Read ↗

Developments in Genetics – a Better Management of Ovarian Cancer PatientsSemantic proximity Read ↗

Developments in Genetics: Better Management of Ovarian Cancer Patients.Semantic proximity Read ↗

Managing hereditary breast cancer risk in women with and without ovarian cancer.Semantic proximity Read ↗

Ovarian cancer risk management in BRCA-mutation carriers: A comparison of six international and national guidelines.Semantic proximity Read ↗

Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2015.Semantic proximity Read ↗

Prevention of Ovarian Cancer: Where are We Now and Where are We Going?Semantic proximity Read ↗

Ovarian Cancer: From Precursor Lesion Identification to Population-Based Prevention ProgramsSemantic proximity Read ↗

Management challenges in low-grade serous ovarian cancer with a BRCA mutation.Semantic proximity Read ↗

Hereditary ovarian cancers: state of the artSemantic proximity Read ↗

Epidemiological and molecular aspects of ovarian cancer risk.Semantic proximity Read ↗

NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2017.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.